Laurel Wealth Advisors (North Carolina)’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Laurel Wealth Advisors (North Carolina)’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4	Closed	-$59	–	601
2023 Q1	$59	Hold	4	–	–	﹤0.01%	580
2022 Q4	$30	Buy	+4	New	+$28	﹤0.01%	561
2022 Q2	–	Sell	-4	Closed	–	–	711
2022 Q1	$0	Hold	4	–	–	﹤0.01%	710
2021 Q4	$0	Hold	4	–	–	﹤0.01%	706
2021 Q3	$0	Hold	4	–	–	﹤0.01%	773
2021 Q2	$0	Buy	+4	New	+$50	﹤0.01%	768

Laurel Wealth Advisors (North Carolina)'s AMYT Position: Q2 2023 in Review

Laurel Wealth Advisors (North Carolina) sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 4 shares — an estimated $59 sold.

Laurel Wealth Advisors (North Carolina) first reported a position in AMYT in Q2 2021 and held it in 6 quarters. The position peaked at $59 in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

Laurel Wealth Advisors (North Carolina) reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Laurel Wealth Advisors (North Carolina) sold 4 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $59.
Laurel Wealth Advisors (North Carolina) first reported a position in Amryt Pharma plc American Depositary Shares in Q2 2021 and held it in 6 quarters.
Laurel Wealth Advisors (North Carolina)'s Amryt Pharma plc American Depositary Shares position peaked at $59 in Q1 2023.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q2 2023, filed 15 Aug 2023.